A detailed history of Chris Bulman Inc transactions in Amgen Inc stock. As of the latest transaction made, Chris Bulman Inc holds 2 shares of AMGN stock, worth $665. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$665
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $525 - $638
2 New
2 $625,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chris Bulman Inc Portfolio

Follow Chris Bulman Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chris Bulman Inc, based on Form 13F filings with the SEC.

News

Stay updated on Chris Bulman Inc with notifications on news.